Recombinant Human Erythropoietin Beta
Written By Dr. Swati Mishra
Reviewed By Dr. Rajeev SharmaLast updated 05 Sep 2023 | 07:34 AM (UTC)
Recombinant Human Erythropoietin Beta Uses
Recombinant Human Erythropoietin Beta is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.
How Recombinant Human Erythropoietin Beta works
Recombinant Human Erythropoietin Beta belongs to a class of medicines called erythropoietin-stimulating agents (ESAs). These medicines work by stimulating the production of red blood cells (RBCs) in the bone marrow. From the bone marrow, these RBCs are released into the bloodstream. This helps in treating anemia in patients who have chronic kidney disease or who are undergoing chemotherapy.
Common side effects of Recombinant Human Erythropoietin Beta
Headache, Diarrhea, Nausea, Vomiting, Hypersensitivity
Want to Know More
Read Our Editorial PolicyMedicine brands for Recombinant Human Erythropoietin Beta
Expert advice for Recombinant Human Erythropoietin Beta
- It is given as a single injection under your skin but if you are on hemodialysis, it will be given into your vein.
- Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures).
- Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells, and electrolytes such as potassium in your blood.
- Inform your doctor if you had a heart attack or stroke in the month before your treatment, if you have new or increasing chest pain or if you are at risk of blood clots in the veins.
- Seek medical help immediately if you develop a rash, ulcers of mouth, throat, nose, genitals, and eyes (red and swollen eyes) preceded by fever and/or flu-like symptoms.